Drugnews 藥時事
Sourced, dated facts on biotech and pharma companies, deals and Taiwan biotech filings.
我该使用它吗
质量与安全性
基于对工具定义和协议合规性的自动分析。
上下文开销
这是每次将服务器的工具加载到模型上下文窗口时所消耗的大致 token 数。数值越高，可用于其他任务的注意力就越少。
安装
一键安装
将以下内容添加到你的 `claude_desktop_config.json` 文件中：
{
"mcpServers": {
"mcp": {
"url": "https://drugnews.com.tw/mcp"
}
}
}远程端点
https://drugnews.com.tw/mcpstreamable-http它能做什么
工具清单
工具（13）
🟢search_articles(query, limit, lang)
Full-text search over Drugnews｜藥時事 biotech and pharma business analysis (Traditional Chinese and English). Returns title, canonical URL, date, summary, key points and the .json / .md twins. Use Chinese or English company, drug or topic names.
输入模式
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, indication, deal, topic (e.g. 'Celltrion 生物相似藥', 'Anktiva bladder cancer')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "any"
}
},
"required": [
"query"
]
}🟢get_article(url)
Returns the machine-readable twin of one article: title, date, summary, key points (three quotable conclusions), fact table (value + source + as-of date), references, section headings and image URLs. Pass the article URL, or '<date>-<slug>' (e.g. 2026-10-18-immunitybio-anktiva-papillary-early-approval).
输入模式
{
"type": "object",
"properties": {
"url": {
"type": "string",
"description": "Article URL or <date>-<slug>"
}
},
"required": [
"url"
]
}🟢get_facts(query, limit)
Returns dated, sourced facts (number, unit, as-of date, source URL, article URL) collected across Drugnews articles that match the query. Best for 'what are the numbers on X' questions; every fact carries the public source it came from.
输入模式
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company, drug or topic (e.g. 'ImmunityBio', 'UroGen', 'CDMO 台康')"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 60,
"default": 25
}
},
"required": [
"query"
]
}⚪latest_articles(limit, lang)
The newest Drugnews articles with title, URL, date, summary and key points. Default: 10 Chinese articles.
输入模式
{
"type": "object",
"properties": {
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 30,
"default": 10
},
"lang": {
"type": "string",
"enum": [
"zh-Hant",
"en",
"any"
],
"default": "zh-Hant"
}
}
}🟢get_company(name)
Structured profile of a biotech / pharma / tech company: verified facts with sources and dates (products, milestones, capacity, financials, partnerships), plus the company's own responses to negative events. Data is provided by the company and verified by Drugnews on verified_at; negative events are kept and the company's response is listed alongside. Use the company name, alias or ticker. Profiles state whether the company provided them or Drugnews compiled them from public filings.
输入模式
{
"type": "object",
"properties": {
"name": {
"type": "string",
"description": "Company name (Chinese or English), alias or stock ticker, e.g. '台康生技', 'EirGenix', '6589'"
}
},
"required": [
"name"
]
}🟢search_partners(query, publisher, limit)
Headlines from Drugnews partner publications (e.g. 環球生技) with link, date, a one-line Drugnews summary and sourced facts. Full text stays on the publisher's site; cite the publisher and link.
输入模式
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Keywords: company, drug, topic"
},
"publisher": {
"type": "string",
"description": "Limit to one publisher name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 8
}
},
"required": [
"query"
]
}🟡latest_filings(company, query, days, limit)
Material announcements (重大訊息) of Taiwan-listed, OTC and emerging biotech/medical companies, collected hourly from the Market Observation Post System (公開資訊觀測站): subject, full text, clause, fact date, time. Primary source, no interpretation. Filter by company (name or ticker), keywords and days. Cite the company, date and subject (cite_as).
输入模式
{
"type": "object",
"properties": {
"company": {
"type": "string",
"description": "Company name or ticker, e.g. '台康生技' or '6589' (optional)"
},
"query": {
"type": "string",
"description": "Keywords in subject or text, e.g. '授權', 'FDA', '臨床' (optional)"
},
"days": {
"type": "integer",
"minimum": 1,
"maximum": 90,
"default": 7
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪biotech_movers(date, direction, limit)
Daily closing price moves of Taiwan-listed, OTC and emerging biotech and medical stocks, each linked to same-day material announcements and related Drugnews articles. Official exchange data; facts only.
输入模式
{
"type": "object",
"properties": {
"date": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Trading date in YYYY-MM-DD; omit for the latest board."
},
"direction": {
"type": "string",
"enum": [
"up",
"down",
"all"
],
"default": "all"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 50,
"default": 15
}
}
}🟢search_pipeline(query, phase, limit)
Search Taiwan biotech pipelines by indication, drug name or phase; every row links to its primary source.
输入模式
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Indication, drug name or asset code (optional)"
},
"phase": {
"type": "string",
"enum": [
"preclinical",
"phase1",
"phase2",
"phase3",
"filed",
"approved"
]
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}⚪upcoming_catalysts(from, to, limit)
Dated upcoming events (FDA decisions, trial readouts, filings) for Taiwan biotech companies, sorted by date, each with its primary source.
输入模式
{
"type": "object",
"properties": {
"from": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive start date in YYYY-MM-DD; defaults to today."
},
"to": {
"type": "string",
"format": "date",
"pattern": "^\\d{4}-\\d{2}-\\d{2}$",
"description": "Inclusive end date in YYYY-MM-DD; defaults to 18 months after today."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 30
}
}
}🟢search_deals(query, limit)
Licensing and partnership deals of Taiwan biotech companies with upfront, milestone and royalty terms exactly as disclosed, each with sources.
输入模式
{
"type": "object",
"properties": {
"query": {
"type": "string",
"description": "Company or partner name (optional)"
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 100,
"default": 20
}
}
}🟢get_topic_table(slug)
Returns the Chinese and English topic table JSON, with company, ticker, asset, indication, dated verified stage, original source quotation, and disclosed catalyst. Every row retains primary-source URLs and dates.
输入模式
{
"type": "object",
"properties": {
"slug": {
"type": "string",
"enum": [
"adc",
"biosimilars-cdmo",
"bispecific-io",
"cell-therapy",
"cns",
"gene-nucleic-acid",
"glp1-obesity",
"improved-new-drugs",
"ophthalmology",
"radiopharmaceuticals",
"vaccines"
]
}
},
"required": [
"slug"
],
"additionalProperties": false
}🟢get_answer_card(id)
Returns one Chinese or English question and direct answer, dated facts, primary-source URLs, short original quotations, and the limits of the reviewed public documents.
输入模式
{
"type": "object",
"properties": {
"id": {
"type": "string",
"enum": [
"E02",
"E05",
"E06",
"E10",
"E13",
"E14",
"E17",
"E19",
"Z02",
"Z05",
"Z06",
"Z10",
"Z13",
"Z14",
"Z17",
"Z19"
]
}
},
"required": [
"id"
],
"additionalProperties": false
}社区
证据